Trial Profile
Efficacy and safety of anticholinergic agents applied for day-time or night-time
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Oct 2016
Price :
$35
*
At a glance
- Drugs Tolterodine (Primary)
- Indications Overactive bladder
- Focus Adverse reactions
- 02 Oct 2016 Status changed from not yet recruiting to completed.
- 03 Nov 2011 New trial record